ABSTRACT
This study assesses the morphogenesis of the primary and secondary jaw joints. A collection of 11 murine heads, ranging from prenatal stage E13.5 to postnatal stage P10, were prepared as histological serial sections (thickness 8-10 µm) and stained conventionally in order to examine them with light microscopy. Next, the regions of the developing temporomandibular joint and the middle ear ossicles were three dimensionally reconstructed using AnalySIS® software. This study gained new insight into the spatio-temporal development of the temporomandibular joint and the auditory ossicles. Furthermore, we newly visualized in 3D that during the developmental period from stages E16 to P4 two morphologically well-functional joints (the primary and secondary jaw joints) exist on either side and are mechanically connected via Meckel's cartilage. Potential separation mechanisms of these two joints are discussed and options for mathematical analysis are suggested.
Subject(s)
Jaw , Temporomandibular Joint , Mice , AnimalsABSTRACT
BACKGROUND: Thrombotic microangiopathy (TMA) is a complication of malignant hypertension (mHTN) attributed to high blood pressure (BP). However, no studies have investigated in patients with mHTN of different aetiologies whether the presence of TMA is associated with specific causes of mHTN. METHODS: We investigated the presence of TMA (microangiopathic haemolytic anaemia and thrombocytopenia) in a large and well-characterized cohort of 199 patients with mHTN of different aetiologies [primary HTN 44%, glomerular diseases 16.6%, primary atypical haemolytic uraemic syndrome (aHUS) 13.1%, renovascular HTN 9.5%, drug-related HTN 7%, systemic diseases 5.5%, endocrine diseases 4.5%]. Outcomes of the study were kidney recovery and kidney failure. RESULTS: Patients with TMA [40 cases (20.1%)] were younger, were more likely female and had lower BP levels and worse kidney function at presentation. Their underlying diseases were primary aHUS (60%), drug-related mHTN (15%), glomerular diseases [all of them immunoglobulin A nephropathy (IgAN); 10%], systemic diseases (10%) and primary HTN (5%). The presence of TMA was 92.3% in primary aHUS, 42.9% in drug-related HTN, 36.4% in systemic diseases, 12.1% in glomerular diseases and 2.3% in primary HTN. No patient with renovascular HTN or mHTN caused by endocrine diseases developed TMA, despite BP levels as high as patients with TMA. A higher proportion of TMA patients developed kidney failure as compared with patients without TMA (56.4% versus 38.9%, respectively). CONCLUSIONS: The presence of TMA in patients with mHTN should guide the diagnosis towards primary aHUS, drug-related mHTN, some systemic diseases and IgAN, while it is exceptional in other causes of mHTN.
Subject(s)
Atypical Hemolytic Uremic Syndrome , Hypertension, Malignant , Hypertension , Kidney Diseases , Purpura, Thrombotic Thrombocytopenic , Renal Insufficiency , Thrombotic Microangiopathies , Humans , Female , Hypertension, Malignant/complications , Thrombotic Microangiopathies/complications , Purpura, Thrombotic Thrombocytopenic/complications , Purpura, Thrombotic Thrombocytopenic/diagnosis , Kidney , Atypical Hemolytic Uremic Syndrome/diagnosis , Kidney Diseases/complications , Renal Insufficiency/complications , Hypertension/complicationsABSTRACT
BACKGROUND: During physiological function of the temporomandibular joint, we have to rely only on elastic structures (in particular the bilaminar zone) for repositioning of the articular disc. A real muscle, however, would be functionally more reasonable. In patients, a decrease of this elasticity is possibly one of the reasons for temporomandibular joint malfunctions, which affect between 16% and 36% of the population. METHOD: This study assesses the morphogenesis of the murine (Mus musculus) temporomandibular joint with particular regard to the masticatory muscles, to throw light on this topic. To that end, a collection of 11 murine heads ranging from prenatal stages E13.25 to E20 was used and early postnatal stages P0 to P4, which were prepared as histological sections (thickness 8-10 µm) and stained conventionally in order to examine them with light microscopy. Next, the temporomandibular joint and selected surrounding structures, along with the masticatory muscles, were threedimensionally reconstructed using analySIS® software. Subsequently, specific morphometric analyses were performed. RESULTS AND CONCLUSIONS: The evaluation of the results led to the following conclusions.
Subject(s)
Pterygoid Muscles , Temporomandibular Joint , Animals , Humans , Masticatory Muscles , MiceABSTRACT
BACKGROUND: The use of cardiac computed tomography (cardiac CT) and the quantification of the Agatston score for the evaluation of calcium of the aortic valve (AVC) has increased in different clinical contexts for diagnostic and prognostic purposes. This study aims to evaluate the correlation between cardiac CT and histopathology for the quantification of AVC. METHODS: Ninety patients diagnosed with severe aortic valve dysfunction, of any etiology and regardless of the predominant type of injury, were included. Before the surgical event, a Cardiac CT were performed with Agatston Score measurement. The removed native valve was evaluated by a Pathologist, who provided a qualitative and quantitative evaluation of valve calcium. Calcium density was also analyzed by quantifying the area in pixel units obtained from photomicrographs. Follow-up was performed for four years after the aortic valve replacement. RESULTS: Ninety patients were analyzed. The degenerative etiology predominated 63.3% (57 patients). The calcium load was different for the gender (pâ¯=â¯0.01) and type of valve injury (pâ¯=â¯0.0013). There was a positive correlation between the Agatston score, and the percentage of calcium reported by the pathologist in a conventional qualitative way (rsâ¯=â¯0.75, p < 0.001) and between the AVC and the Cote et al. score (rsâ¯=â¯0.77, p < 0.001). There was no difference in survival after aortic valve replacement concerning valve calcium load. Left ventricular dysfunction showed a significant difference in survival (pâ¯=â¯0.003, Log-rank). CONCLUSION: There is a moderately high correlation between the Agatston score quantified by Cardiac CT and the histopathological evaluation. The severity of the calcification did not prove to be a predictor of death in the postsurgical follow-up.
Subject(s)
Aortic Valve Disease , Aortic Valve Stenosis , Aortic Valve/diagnostic imaging , Aortic Valve/pathology , Aortic Valve/surgery , Aortic Valve Stenosis/diagnostic imaging , Aortic Valve Stenosis/surgery , Calcium , Humans , Severity of Illness Index , Tomography, X-Ray Computed/adverse effectsABSTRACT
ANTECEDENTES Y OBJETIVO: En diciembre de 2019 surgió en Wuhan, China, la COVID-19, causada por el virus SARS-CoV-2 y declarada pandemia global por la Organización Mundial de la Salud en marzo de 2020. Es una infección respiratoria con complicaciones a nivel cardiaco, hematológico, digestivo, neurológico y renal. El fracaso renal agudo (FRA) en pacientes hospitalizados por COVID-19 se presenta en el 0,5-25% y es un factor de mal pronóstico. Los mecanismos de afectación renal no están completamente aclarados. Presentamos la evolución clínica de pacientes ingresados por COVID-19 con FRA que requirieron atención por Nefrología en un hospital terciario de la Comunidad de Madrid, España. MÉTODOS: Este es un estudio observacional prospectivo de todos los casos que ingresaron por COVID-19 entre el 6 de marzo y el 12 de mayo de 2020 y requirieron atención por Nefrología. Se recogieron datos clínicos y analíticos de características basales, y la evolución de la COVID-19 y del FRA. RESULTADOS: Se analizaron 41 pacientes con una edad media de 66,8 años (DE 2,1), el 90,2% varones, y con enfermedad renal crónica previa en el 36,6%. El 56,1% presentaron neumonía grave o síndrome de distrés respiratorio agudo y el 31,7% requirió ingreso en UCI. El FRA fue de etiología prerrenal en el 61%, necrosis tubular aguda en contexto de sepsis en el 24,4%, glomerular en el 7,3% y por toxicidad tubular en el 7,3%. Se registró proteinuria en el 88,9% y hematuria en el 79,4%. El 48,8% de los pacientes requirió terapia de sustitución renal. La mediana de estancia fue de 12 días (RIC 9-23), y el 22% fallecieron. Los pacientes que desarrollaron FRA durante el ingreso presentaron valores más altos de proteína C reactiva, LDH y dímero-D, una afectación pulmonar más grave, más necesidad de ingreso en UCI, más tratamiento con lopinavir/ritonavir y fármacos biológicos, y mayor necesidad de terapia de sustitución renal. CONCLUSIONES: La hipovolemia y la deshidratación son una causa frecuente de FRA en pacientes con COVID-19. Aquellos que desarrollan FRA intrahospitalario presentan un perfil de peor pronóstico respiratorio, analítico y renal. Creemos que la monitorización de marcadores renales, así como el manejo individualizado de la volemia, pueden ser determinantes para prevenir el FRA
BACKGROUND AND AIM: In December 2019, a coronavirus 2019 (COVID-19) outbreak, caused by SARS-CoV-2, took place in Wuhan, China, and was declared a global pandemic in March 2020 by the World Health Organization. It is a prominently respiratory infection, with potential cardiological, hematological, gastrointestinal and renal complications. Acute kidney injury (AKI) is found in 0.5-25% of hospitalized COVID-19 patients and constitutes a negative prognostic factor. Renal damage mechanisms are not completely clear. We report the clinical evolution of hospitalized COVID-19 patients who presented with AKI requiring attention from the Nephrology team in a tertiary hospital in Madrid, Spain. METHODS: This is an observational prospective study including all COVID-19 cases that required hospitalization and Nephrology management from March 6th to May 12th 2020. We collected clinical and analytical data of baseline characteristics, COVID-19 and AKI evolutions. RESULTS: We analyzed 41 patients with a mean age of 66.8 years (SD 2.1), 90.2% males, and with a history of chronic kidney disease in 36.6%. A percentage of 56.1 presented with severe pneumonia or acute respiratory distress syndrome, and 31.7% required intensive care. AKI etiology was prerenal in 61%, acute tubular necrosis in the context of sepsis in 24.4%, glomerular in 7.3% and tubular toxicity in 7.3% of the cases. We reported proteinuria in 88.9% and hematuria in 79.4% of patients. A percentage of 48.8 required renal replacement therapy. Median length of stay was 12 days (IQR 9-23) and 22% of the population died. Patients who developed AKI during hospital stay presented with higher C-reactive protein, LDH and D-dimer values, more severe pulmonary damage, more frequent ICU admission, treatment with lopinavir/ritonavir and biological drugs and renal replacement therapy requirement. CONCLUSIONS: Hypovolemia and dehydration are a frequent cause of AKI among COVID-19 patients. Those who develop AKI during hospitalization display worse prognostic factors in terms of pulmonary damage, renal damage, and analytical findings. We believe that monitorization of renal markers, as well as individualized fluid management, can play a key role in AKI prevention
Subject(s)
Humans , Male , Middle Aged , Aged , Acute Kidney Injury/therapy , Betacoronavirus , Coronavirus Infections/complications , Pneumonia, Viral/complications , Pandemics , Hospitalization , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Prospective Studies , Acute Kidney Injury/drug therapy , Lopinavir/therapeutic use , Ritonavir/therapeutic use , Renal Dialysis/methods , Hydroxychloroquine/therapeutic use , Azithromycin/therapeutic use , Adrenal Cortex Hormones/therapeutic useABSTRACT
BACKGROUND AND AIM: In December 2019, a coronavirus 2019 (COVID-19) outbreak, caused by SARS-CoV-2, took place in Wuhan and was declared a global pandemic in March 2020 by the World Health Organization (WHO). It is a prominently respiratory infection, with potential cardiological, hematological, gastrointestinal and renal complications. Acute kidney injury (AKI) is found in 0.5%-25% of hospitalized COVID-19 patients and constitutes a negative prognostic factor. Renal damage mechanisms are not completely clear. We report the clinical evolution of hospitalized COVID-19 patients who presented with AKI requiring attention from the Nephrology team in a tertiary hospital in Madrid, Spain. METHODS: This is an observational prospective study including all COVID-19 cases that required hospitalization and Nephrology management from March 6th to May 12th. We collected clinical and analytical data of baseline characteristics, COVID-19 and AKI evolutions. RESULTS: We analyzed 41 patients with a mean age of 66.8 years (SD 2.1), 90.2% males, and with a history of chronic kidney disease (CKD) in 36.6%. 56.1% of patients presented with sever pneumonia or acute respiratory distress syndrome (ARDS), and 31.7% required intensive care. AKI etiology was prerenal in 61%, acute tubular necrosis in the context of sepsis in 24.4%, glomerular in 7.3% and tubular toxicity in 7.3% of the cases. We reported proteinuria in 88.9% and hematuria in 79.4% of patients. 48.8% of patients required renal replacement therapy (RRT). Median length of stay was 12 days (interquartilic range 9-23) and 22% of the population died. Patients who developed AKI during hospital stay presented with higher C-reactive protein, Lactate dehydrogenase-LDH and d-dimer values, more severe pulmonary damage, more frequent intensive care unit-ICU admission, treatment with lopinavir/ritonavir and biological drugs and RRT requirement. CONCLUSIONS: Hypovolemia and dehydration are a frequent cause of AKI among COVID-19 patients. Those who develop AKI during hospitalization display worse prognostic factors in terms of pulmonary damage, renal damage, and analytical findings. We believe that monitorization of renal markers as well as individualized fluid management can play a key role in AKI prevention.
ABSTRACT
BACKGROUND AND AIM: In December 2019, a coronavirus 2019 (COVID-19) outbreak, caused by SARS-CoV-2, took place in Wuhan, China, and was declared a global pandemic in March 2020 by the World Health Organization. It is a prominently respiratory infection, with potential cardiological, hematological, gastrointestinal and renal complications. Acute kidney injury (AKI) is found in 0.5-25% of hospitalized COVID-19 patients and constitutes a negative prognostic factor. Renal damage mechanisms are not completely clear. We report the clinical evolution of hospitalized COVID-19 patients who presented with AKI requiring attention from the Nephrology team in a tertiary hospital in Madrid, Spain. METHODS: This is an observational prospective study including all COVID-19 cases that required hospitalization and Nephrology management from March 6th to May 12th 2020. We collected clinical and analytical data of baseline characteristics, COVID-19 and AKI evolutions. RESULTS: We analyzed 41 patients with a mean age of 66.8 years (SD 2.1), 90.2% males, and with a history of chronic kidney disease in 36.6%. A percentage of 56.1 presented with severe pneumonia or acute respiratory distress syndrome, and 31.7% required intensive care. AKI etiology was prerenal in 61%, acute tubular necrosis in the context of sepsis in 24.4%, glomerular in 7.3% and tubular toxicity in 7.3% of the cases. We reported proteinuria in 88.9% and hematuria in 79.4% of patients. A percentage of 48.8 required renal replacement therapy. Median length of stay was 12 days (IQR 9-23) and 22% of the population died. Patients who developed AKI during hospital stay presented with higher C-reactive protein, LDH and D-dimer values, more severe pulmonary damage, more frequent ICU admission, treatment with lopinavir/ritonavir and biological drugs and renal replacement therapy requirement. CONCLUSIONS: Hypovolemia and dehydration are a frequent cause of AKI among COVID-19 patients. Those who develop AKI during hospitalization display worse prognostic factors in terms of pulmonary damage, renal damage, and analytical findings. We believe that monitorization of renal markers, as well as individualized fluid management, can play a key role in AKI prevention.
Subject(s)
Acute Kidney Injury/etiology , COVID-19/complications , Pandemics , SARS-CoV-2 , Acute Kidney Injury/mortality , Acute Kidney Injury/therapy , Aged , COVID-19/epidemiology , COVID-19/mortality , Female , Hospitalization/statistics & numerical data , Humans , Intensive Care Units , Male , Patient Discharge/statistics & numerical data , Prognosis , Prospective Studies , Renal Replacement Therapy/statistics & numerical data , Spain/epidemiology , Statistics, NonparametricABSTRACT
Resumen OBJETIVO: Describir la técnica Ramírez-Maksymenko (ligadura de arterias hipogástricas, ováricas, Sampson) y mostrar que la angiotomografía computada pélvica inmediata favorece la disminución de la morbilidad y mortalidad materna por hemorragia obstétrica. MATERIALES Y MÉTODOS: Estudio prospectivo efectuado entre los meses de mayo de 2019 a marzo de 2020. Se incluyeron pacientes con hemorragia obstétrica postoperadas con la técnica Ramírez-Maksymenko, con seguimiento por angiotomografía computada pélvica y observación de las principales arterias que irrigan al útero, conforme al tiempo posterior a la cirugía hasta retornar a la normalidad. RESULTADOS: Se estudiaron 5 pacientes que en la angiotomografía computada pélvica posoperatoria se encontraron con adecuada vascularidad uterina por las arterias: sacra media, iliolumbares, vaginales y ováricas. Todas las pacientes retornaron a la normalidad aproximadamente a los 3 meses 14 días. El diámetro de las hipogástricas al día siguiente del posoperatorio fue de 1 mm y a los 3 meses 14 días de 4 mm (normal). CONCLUSIONES: Con esta técnica se evitan transfusiones masivas, ingreso a terapia intensiva; además, disminuye la vascularidad uterina y se favorece el más rápido retorno a la normalidad. Con esta técnica de desarterialización, el útero continúa con adecuada vascularidad por las arterias iliolumbares, sacras medias, vaginales y ramas de las arterias ováricas, a pesar de encontrarse ligadas, lo que debe suceder con otras técnicas quirúrgicas donde se ligan. Una sola seda 1 o hilo crómico del 2-0 es suficiente para disminuir el diámetro de las hipogástricas; algunas técnicas utilizan dos suturas. En 3 meses 14 días, aproximadamente, la circulación regresa a la normalidad.
Abstract OBJECTIVE: To describe the Ramírez-Maksymenko technique (ligation of hypogastric, ovarian, Sampson arteries) and show that immediate pelvic computed tomography angiography favors the decrease in maternal morbidity and mortality due to obstetric hemorrhage. MATERIALS AND METHODS: Prospective study carried out between the months of May 2019 to March 2020. Patients with obstetric hemorrhage postoperated with the Ramírez-Maksymenko technique were included, with follow-up by pelvic computed tomography angiography and observation of the main arteries supplying the uterus, according to the time after surgery until returning to normal. RESULTS: Five patients were studied who, on postoperative pelvic computed tomography angiography, found adequate uterine vascularity through the arteries: medial sacral, iliolumbar, vaginal, and ovarian arteries. All patients returned to normal at approximately 3 months 14 days. The diameter of the hypogastric patients the day after the postoperative period was 1 mm and at 3 months 14 days 4 mm (normal). CONCLUSIONS: With this technique, massive transfusions, admission to intensive care, reduction of uterine vascularity are avoided, and a faster return to normal is favored.With this dearterialization technique, the uterus continues with adequate vascularity through the iliolumbar, middle sacral, vaginal, and branches of the ovarian arteries, despite being linked, which should happen with other surgical techniques where they are ligated. A single silk 1 or 2-0 chromic thread is sufficient to decrease the diameter of the hypogastric; some techniques use two sutures. In approximately 3 months and 14 days, the circulation returns to normal.
ABSTRACT
The devastating consequences of cyberbullying during adolescence justify the relevance of obtaining empirical evidence on the factors that may cause participation in its distinct roles. The goal of this study was to analyze the predictive capacity of aggressiveness (physical aggression, verbal aggression, anger, and hostility) and emotional intelligence (attention, understanding, and emotional regulation) with respect to being a victim, aggressor or victim-aggressor of cyberbullying during adolescence. The Screening for Peer Bullying, the Aggressiveness Questionnaire and the Trait Meta-Mood Scale-24 were administered to a sample of 1102 Spanish secondary education students, aged 12 to 18. In general, results revealed a higher probability of being a victim, aggressor or victim-aggressor as physical aggressiveness and anger increased. On the other hand, results revealed a low probability of being a victim, aggressor or victim-aggressor as emotional understanding and emotional regulation increased. These findings highlight the importance of considering said variables when creating prevention programs to stop or reduce the social and educational issue of cyberbullying during adolescence.
Subject(s)
Aggression , Cyberbullying , Emotional Intelligence , Students/psychology , Adolescent , Anger , Child , Female , Humans , Male , Peer Group , Surveys and QuestionnairesABSTRACT
No disponible
Subject(s)
Humans , Female , Middle Aged , Hypercalcemia/chemically induced , Hypercalcemia/diagnosis , Benzhydryl Compounds/adverse effects , Diabetes Mellitus, Type 2/drug therapyABSTRACT
BACKGROUND AND PURPOSE: Radiation oncology guidelines favour hypofractionated whole-breast radiotherapy (HWBRT) over more conventional schemes in the conservative treatment of breast cancer, but its adoption still varies in clinical practice. This study assessed the patterns of HWBRT adoption in Catalonia (Spain). MATERIAL AND METHODS: We used a mixed-methods approach based on an explanatory sequential design, first collecting and analysing quantitative data on HWBRT use (>2.5Gy per fraction) in 11 public radiotherapy centres (2005-2015) and then performing 25 semi-structured interviews with all department heads and reference radiation oncologist/s. RESULTS: Of the 34,859 patients fulfiling the study criteria over the study period, just 12% were hypofractionated, reaching a percentage of 29% in 2015 (p<0.001). Our analysis showed a narrowing age gap between patients receiving conventional fractionation and hypofractionation in centres leading adoption. However, there were important differences in clinicians' interpretation of evidence (e.g. regarding the perceived risk of long-term toxicity) and selection of patients for specific indications, both within and between departments. CONCLUSIONS: Differences observed in the rate of adoption of HWBRT could not be tackled only using a rational, evidence-based approach. Factors related to the management of radiotherapy departments play a major role in the diffusion of therapeutic strategies.
Subject(s)
Breast Neoplasms/radiotherapy , Radiation Dose Hypofractionation , Aged , Female , Humans , Middle Aged , Spain , Treatment OutcomeABSTRACT
No disponible
Subject(s)
Aged , Humans , Male , Glomerulonephritis, IGA/chemically induced , Iodine/adverse effects , Nephritis, Interstitial/prevention & control , Contrast Media/adverse effects , Intracranial Aneurysm/complicationsSubject(s)
Contrast Media/adverse effects , Glomerulonephritis, IGA/complications , Iodine Compounds/adverse effects , Kidney/pathology , Nephritis, Interstitial/chemically induced , Acute Disease , Aged , Biopsy , Cerebral Angiography , Glomerulonephritis, IGA/diagnosis , Glomerulonephritis, IGA/pathology , Humans , Kidney/drug effects , Kidney/immunology , Male , Nephritis, Interstitial/etiology , Nephritis, Interstitial/pathologyABSTRACT
The new Kidney Disease: Improving Global Outcomes (KDIGO) international guidelines on chronic kidney disease (CKD) and the management of blood pressure (BP) in CKD patients are an update of the corresponding 2002 and 2004 KDOQI (Kidney Disease Outcomes Quality Initiative) guidelines. The documents aim to provide updated guidelines on the assessment, management and treatment of patients with CKD. The first guidelines retain the 2002 definition of CKD but present an improved prognosis classification. Furthermore, concepts about prognosis of CKD, recommendations for management of patients, and criteria for referral to the nephrologist have been updated. The second guideline retains the <130/80 mm Hg-goal for management of BP in patients with CKD presenting increased albuminuria or proteinuria (albumin-to-creatinine ratio 30-300 mg/g, and >300 mg/g, respectively) but recommends a less-strict goal of <140/90 mm Hg in patients with normoalbuminuria. The development of the guidelines followed a predetermined process in which the evidence available was reviewed and assessed. Recommendations on management and treatment are based on the systematic review of relevant studies. The GRADE system (Grading of Recommendations Assessment, Development and Evaluation) was used to assess the quality of evidence and issue the grade of recommendation. Areas of uncertainty are also discussed for the different aspects addressed.
Subject(s)
Practice Guidelines as Topic , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/therapy , Disease Progression , Humans , Nephrology , Societies, Medical , SpainABSTRACT
BACKGROUND: Anemia is a common condition in CKD that has been identified as a cardiovascular (CV) risk factor in end-stage renal disease, constituting a predictor of low survival. The aim of this study was to define the onset of anemia of renal origin and its association with the evolution of kidney disease and clinical outcomes in stage 3 CKD (CKD-3). METHODS: This epidemiological, prospective, multicenter, 3-year study included 439 CKD-3 patients. The origin of nephropathy and comorbidity (Charlson score: 3.2) were recorded. The clinical characteristics of patients that developed anemia according to EBPG guidelines were compared with those that did not, followed by multivariate logistic regression, Kaplan-Meier curves and ROC curves to investigate factors associated with the development of renal anemia. RESULTS: During the 36-month follow-up period, 50% reached CKD-4 or 5, and approximately 35% were diagnosed with anemia (85% of renal origin). The probability of developing renal anemia was 0.12, 0.20 and 0.25 at 1, 2 and 3 years, respectively. Patients that developed anemia were mainly men (72% anemic vs. 69% non-anemic). The mean age was 68 vs. 65.5 years and baseline proteinuria was 0.94 vs. 0.62 g/24h (anemic vs. non anemic, respectively). Baseline MDRD values were 36 vs. 40 mL/min and albumin 4.1 vs. 4.3 g/dL; reduction in MDRD was greater in those that developed anemia (6.8 vs. 1.6 mL/min/1.73 m2/3 years). These patients progressed earlier to CKD-4 or 5 (18 vs. 28 months), with a higher proportion of hospitalizations (31 vs. 16%), major CV events (16 vs. 7%), and higher mortality (10 vs. 6.6%) than those without anemia. Multivariate logistic regression indicated a significant association between baseline hemoglobin (OR=0.35; 95% CI: 0.24-0.28), glomerular filtration rate (OR=0.96; 95% CI: 0.93-0.99), female (OR=0.19; 95% CI: 0.10-0.40) and the development of renal anemia. CONCLUSIONS: Renal anemia is associated with a more rapid evolution to CKD-4, and a higher risk of CV events and hospitalization in non-dialysis-dependent CKD patients. This suggests that special attention should be paid to anemic CKD-3 patients.